5-(Methylsulfonyl)indoline

Catalog No.: 
ACJHAT325
CAS No.: 
387350-92-7
Molecular Formula: 
C9H11NO2S
Molecular Weight: 
197.26
5-(Methylsulfonyl)indoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$179.00In stockIn stock
25g95%$868.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Methylsulfonyl)indoline
IUPAC Name5-(methylsulfonyl)indoline
MDL No.MFCD01319203
Molecular FormulaC9H11NO2S
Molecular Weight197.26
SMILESCS(=O)(=O)C1=CC2=C(NCC2)C=C1
InChI KeyOFYOHQMIBTVTKY-UHFFFAOYSA-N
Synonym5-(METHYLSULFONYL)-INDOLINE;5-(Methylsulphonyl)indoline 95+%;5-methylsulfonyl-2,3-dihydro-1H-indole;1-(Cloromethyl)-4,5-dihydro-1H-imidazole hydrochloride;5-(Methylsulphonyl)indoline;2,3-Dihydro-5-(methylsulphonyl)-1H-indole, 2,3-Dihydro-1H-indol-5-yl methyl sulphone;1-(CHLOROMETHYL)-4,5-DIHYDRO-1H-IMIDAZOLE HYDROCHLORIDE;1H-Indole, 2,3-dihydro-5-(methylsulfonyl)-
CAS No.387350-92-7
PubChem CID2736136

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJHAT325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCXKO705 route compound structure diagram
    ACCXKO705152879-73-7In Stock
  2. Then
  3. ACJHAT325 route product structure diagram
    ACJHAT325387350-92-7In Stock
Inquiry

2. ACJHAT325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJHAT325 route product structure diagram
    ACJHAT325387350-92-7In Stock
Inquiry

3. ACJHAT325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJHAT325 route product structure diagram
    ACJHAT325387350-92-7In Stock
Inquiry

Comments (0)